1-3 of 3
Taras A Gritsenko, MD PhD
Close
Sort by
Journal Articles

Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician’s and Patient’s Perspective

Tatyana I Ionova, PhD, Tatyana P Nikitina, PhD, Denis A Fedorenko, MD PhD, Taras A Gritsenko, MD PhD, Valentina L Ivanova, MD PhD, Galina B Kuchma, MD PhD, Tatyana V Shnaider, MD PhD, Inga V Sannikova, MD PhD, Elena I Usacheva, MD PhD, Kira A Kurbatova
Journal: Blood
Blood (2014) 124 (21): 2644.
https://doi.org/10.1182/blood.V124.21.2644.2644
Published: 2014
Journal Articles

Efficacy Of Dasatinib Therapy In Patients With Imatinib-Resistant Or -Intolerant Chronic Myeloid Leukemia From Physician’s and Patient’s Perspective: “Real World” Data

Tatyana I Ionova, PhD, Tatyana P Nikitina, MD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Inga V Sannikova, MD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova
Journal: Blood
Blood (2013) 122 (21): 5185.
https://doi.org/10.1182/blood.V122.21.5185.5185
Published: 2013
Journal Articles

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Tatyana I Ionova, PhD, Tatiana P Nikitina, PhD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova, Andrei A Novik, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4445.
https://doi.org/10.1182/blood.V120.21.4445.4445
Published: 2012